Su, Xinming

The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling. [electronic resource] - The Journal of clinical investigation Oct 2012 - 3579-92 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

1558-8238

10.1172/JCI38576 doi


Adenosine Diphosphate--physiology
Animals
Arthritis, Experimental--complications
Bone Neoplasms--complications
Bone Remodeling--drug effects
Bone Resorption--physiopathology
Carcinoma--complications
Cell Adhesion--drug effects
Cells, Cultured--drug effects
Clopidogrel
Enzyme Activation--drug effects
Female
Mammary Neoplasms, Experimental--pathology
Mice
Mice, Inbred C57BL
Mice, Knockout
Osteoclasts--physiology
Osteoporosis--etiology
Ovariectomy
Phosphatidylinositol 3-Kinases--physiology
Phosphoinositide-3 Kinase Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex--drug effects
Purinergic P2Y Receptor Antagonists--pharmacology
Receptors, Purinergic P2Y12--deficiency
Specific Pathogen-Free Organisms
Ticlopidine--analogs & derivatives
rap1 GTP-Binding Proteins--drug effects